Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C37H40O9 |
Molecular Weight | 628.7081 |
Optical Activity | ( + ) |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12O[C@]4(CC3=CC=CC=C3)O[C@]1(C[C@@H](C)[C@]5(O4)[C@]6([H])C=C(C)C(=O)[C@@]6(O)CC(COC(=O)CC7=CC=C(O)C(OC)=C7)=C[C@@]25[H])C(C)=C
InChI
InChIKey=DSDNAKHZNJAGHN-MXTYGGKSSA-N
InChI=1S/C37H40O9/c1-21(2)35-17-23(4)37-27(33(35)44-36(45-35,46-37)19-24-9-7-6-8-10-24)14-26(18-34(41)30(37)13-22(3)32(34)40)20-43-31(39)16-25-11-12-28(38)29(15-25)42-5/h6-15,23,27,30,33,38,41H,1,16-20H2,2-5H3/t23-,27+,30-,33-,34-,35-,36-,37-/m1/s1
Molecular Formula | C37H40O9 |
Molecular Weight | 628.7081 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Resiniferatoxin (RTX or RTX-107) is a vanilloid derived from a cactus-like plant (Euphoria resiniferous) and has anti-inflammatory activity. This compound is an agonist of the transient receptor potential vanilloid 1 (TRPV1). Resiniferatoxin produces analgesia by desensitizing the TRPV1 receptor. Findings of several studies have suggested a potential therapeutic use of the anti-inflammatory effect of resiniferatoxin. Phase I and II clinical trials have been completed or are underway, evaluating the safety and efficacy of resiniferatoxin in pain-related disorders such as osteoarthritis and cancers.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL4794 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27563913 |
PubMed
Title | Date | PubMed |
---|---|---|
Effect of resiniferatoxin on the isolated rabbit iris sphincter muscle: comparison with capsaicin and bradykinin. | 1992 Mar 24 |
|
Analysis of the native quaternary structure of vanilloid receptor 1. | 2001 Jul 27 |
|
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. | 2001 Oct |
|
High affinity antagonists of the vanilloid receptor. | 2002 Oct |
|
Ischemic preconditioning of remote organs attenuates gastric ischemia-reperfusion injury through involvement of prostaglandins and sensory nerves. | 2004 Sep 19 |
|
Inhibitory effect of PACAP-38 on acute neurogenic and non-neurogenic inflammatory processes in the rat. | 2007 Sep |
|
Preventive effect of TRPV1 agonists capsaicin and resiniferatoxin on ischemia/reperfusion-induced renal injury in rats. | 2008 May |
|
Regulation of the benzamil-insensitive salt taste receptor by intracellular Ca2+, protein kinase C, and calcineurin. | 2009 Sep |
|
Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis. | 2011 Dec 1 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 14:32:06 GMT 2023
by
admin
on
Sat Dec 16 14:32:06 GMT 2023
|
Record UNII |
A5O6P1UL4I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C2198
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
||
|
FDA ORPHAN DRUG |
164802
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
57444-62-9
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
5702546
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
GH-167
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
RESINIFERATOXIN
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
A5O6P1UL4I
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
11485
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
8809
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
DTXSID00894764
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
C1214
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
C024353
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
100000175504
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY | |||
|
DB06515
Created by
admin on Sat Dec 16 14:32:06 GMT 2023 , Edited by admin on Sat Dec 16 14:32:06 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|